Citation Tools

Download PDFPDF

721 AT1412, a patient-derived CD9 antibody in preclinical development promoting tumor immune infiltration and inducing tumor rejection

Download to a citation manager

Cite this article as:
Schotte R, Villaudy J, Kedde M, et al
721 AT1412, a patient-derived CD9 antibody in preclinical development promoting tumor immune infiltration and inducing tumor rejection